Advanced search
Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 114, 2008 - Issue 1: Special Issue: Proceedings of the Workshop on Insulin and Cancer, Dusseldorf, October 2007
Submit an article Journal homepage
740
Views
241
CrossRef citations to date
0
Altmetric
Review

Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies

Paola Pisani Cancer Epidemiology Unit, Richard Doll Building, The Oxford University, Old Road Campus, Roosevelt Drive, Headington, Oxford, OX3 7LF
Pages 63-70 | Received 07 Jan 2008, Accepted 31 Jan 2008, Published online: 10 Oct 2008

Citations (241)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Öner Aynιoglu, Rahime Nida Ergin, Yigit Çakιroglu & Eray Çalιşkan. (2017) Pregnancy with Concomitant Pancreatic Cancer. Baylor University Medical Center Proceedings 30:3, pages 289-290.
Read now
Nicoletta Provinciali, Matteo Lazzeroni, Massimiliano Cazzaniga, Franco Gorlero, Barbara K Dunn & Andrea DeCensi. (2015) Metformin: risk-benefit profile with a focus on cancer. Expert Opinion on Drug Safety 14:10, pages 1573-1585.
Read now
Dana J. Herrigel & Rebecca A. Moss. (2014) Diabetes Mellitus as a Novel Risk Factor for Gastrointestinal Malignancies. Postgraduate Medicine 126:6, pages 106-118.
Read now
SusanR. Sturgeon, StellaL. Volpe, Elaine Puleo, ElizabethR. Bertone-Johnson, Joanna Heersink, Sara Sabelawski, Kristina Wähälä, Carol Bigelow & MindyS. Kurzer. (2011) Dietary Intervention of Flaxseed: Effect on Serum Levels of IGF-1, IGF-BP3, and C-Peptide. Nutrition and Cancer 63:3, pages 376-380.
Read now
RebeccaL. Sedjo, RalphB. D’Agostino$suffix/text()$suffix/text(), Dennis Ahnen, TheodoreR. Levin, StevenM. Haffner, JanetA. Tooze & Tim Byers. (2011) Lack of Association Between Insulin Sensitivity and Colorectal Adenoma Risk. Nutrition and Cancer 63:1, pages 6-11.
Read now
Susen Becker, Laure Dossus & Rudolf Kaaks. (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Archives of Physiology and Biochemistry 115:2, pages 86-96.
Read now
Juergen Sandow. (2009) Growth effects of insulin and insulin analogues. Archives of Physiology and Biochemistry 115:2, pages 72-85.
Read now

Articles from other publishers (234)

Anni M.Y. Zhang, Yi Han Xia, Jeffrey S.H. Lin, Ken H. Chu, Wei Chuan K. Wang, Titine J.J. Ruiter, Jenny C.C. Yang, Nan Chen, Justin Chhuor, Shilpa Patil, Haoning Howard Cen, Elizabeth J. Rideout, Vincent R. Richard, David F. Schaeffer, Rene P. Zahedi, Christoph H. Borchers, James D. Johnson & Janel L. Kopp. (2023) Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metabolism 35:12, pages 2119-2135.e5.
Crossref
Nikitha Vobugari & Kai Sun. 2023. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies.
Harinakshi Sanikini, Carine Biessy, Sabina Rinaldi, Anne-Sophie Navionis, Audrey Gicquiau, Pekka Keski-Rahkonen, Agneta Kiss, Stephanie J. Weinstein, Demetrius Albanes, Antonio Agudo, Mazda Jenab, Elio Riboli, Marc J. Gunter, Gwen Murphy & Amanda J. Cross. (2023) Circulating hormones and risk of gastric cancer by subsite in three cohort studies. Gastric Cancer 26:6, pages 969-987.
Crossref
Katharina Nimptsch, Krasimira Aleksandrova, Thu Thi Pham, Nikos Papadimitriou, Jürgen Janke, Sofia Christakoudi, Alicia Heath, Anja Olsen, Anne Tjønneland, Matthias B. Schulze, Verena Katzke, Rudolf Kaaks, Bethany van Guelpen, Justin Harbs, Domenico Palli, Alessandra Macciotta, Fabrizio Pasanisi, Sandra Milena Colorado Yohar, Marcela Guevara, Pilar Amiano, Sara Grioni, Paula Gabriela Jakszyn, Jane C. Figueiredo, N. Jewel Samadder, Christopher I. Li, Victor Moreno, John D. Potter, Robert E. Schoen, Caroline Y. Um, Elisabete Weiderpass, Mazda Jenab, Marc J. Gunter & Tobias Pischon. (2023) Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer. BMC Medicine 21:1.
Crossref
Mitra Kazemi Jahromi, Hamid Ahmadirad, Sanaz Jamshidi, Hossein Farhadnejad, Ebrahim Mokhtari, Tahere Shahrokhtabar, Saeed Tavakkoli, Farshad Teymoori & Parvin Mirmiran. (2023) The association of serum C-peptide with the risk of cardiovascular events: a meta-analysis and systematic review. Diabetology & Metabolic Syndrome 15:1.
Crossref
Olga Partyka, Monika Pajewska, Daria Kwaśniewska, Aleksandra Czerw, Andrzej Deptała, Michał Budzik, Elżbieta Cipora, Izabela Gąska, Lucyna Gazdowicz, Aneta Mielnik, Katarzyna Sygit, Marian Sygit, Edyta Krzych-Fałta, Daria Schneider-Matyka, Szymon Grochans, Anna M. Cybulska, Jarosław Drobnik, Ewa Bandurska, Weronika Ciećko, Piotr Ratajczak, Karolina Kamecka, Michał Marczak & Remigiusz Kozłowski. (2023) Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations. Cancers 15:14, pages 3634.
Crossref
Sylvia H. J. Jochems, Josef Fritz, Christel Häggström, Pär Stattin & Tanja Stocks. (2023) Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study. Cancer Medicine 12:12, pages 13732-13744.
Crossref
Maho Taguchi, Ryotaro Bouchi, Tatsuya Fukuda, Noriko Ihana-Sugiyama, Noriko Kodani, Mitsuru Ohsugi, Akiyo Tanabe, Kohjiro Ueki & Hiroshi Kajio. (2022) Clinical significance of tumor markers in patients with type 2 diabetes: a retrospective observational study. Diabetology International 14:1, pages 40-50.
Crossref
Anni M. Y. Zhang, Ken H. Chu, Brian F. Daly, Titine Ruiter, Yan Dou, Jenny C. C. Yang, Twan J. J. de Winter, Justin Chhuor, Su Wang, Stephane Flibotte, Yiwei Bernie Zhao, Xiaoke Hu, Hong Li, Elizabeth J. Rideout, David F. Schaeffer, James D. Johnson & Janel L. Kopp. (2022) Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics. Cancer & Metabolism 10:1.
Crossref
Qurat-ul-eain-Hyder Rizvi, Rafeeya Shams, Vinay Kumar Pandey, Aamir Hussain Dar, Anjali Tripathi & Rahul Singh. (2022) A descriptive review on nutraceutical constituents, detoxification methods and potential health benefits of flaxseed. Applied Food Research 2:2, pages 100239.
Crossref
Ethan Lazarus & Harold Edward Bays. (2022) Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 3, pages 100026.
Crossref
Sherry Shen & Neil M. Iyengar. (2022) Insulin-Lowering Diets in Metastatic Cancer. Nutrients 14:17, pages 3542.
Crossref
Lingwen Gu, Guofeng Ma, Cui Li, Jing Lin & Guiqiu Zhao. (2022) New insights into the prognosis of intraocular malignancy: Interventions for association mechanisms between cancer and diabetes. Frontiers in Oncology 12.
Crossref
Gieira S. Jones, Barry I. Graubard, Yesenia Ramirez, Linda M. Liao, Wen-Yi Huang, Christian S. Alvarez, Wanshui Yang, Xuehong Zhang, Jessica L. Petrick & Katherine A. McGlynn. (2022) Sweetened beverage consumption and risk of liver cancer by diabetes status: A pooled analysis. Cancer Epidemiology 79, pages 102201.
Crossref
Shu-Hua Hsu, De-Kai Syu, Yu-Chiao Wang, Chih-Kuang Liu & Ming-Chih Chen. (2022) Metformin, Statin Use, and Female Colorectal Cancer: A Population-Based Cohort Study in Taiwan. Journal of Clinical Medicine 11:15, pages 4469.
Crossref
Anastasios Tentolouris, Ioannis Ntanasis‐Stathopoulos, Ioanna Eleftheriadou, Panagiotis Malandrakis, Evangelia Tzeravini & Maria Gavriatopoulou. (2022) Diabetes mellitus and multiple myeloma; common features of two distinct entities. Diabetes/Metabolism Research and Reviews 38:5.
Crossref
Saud S Alharbi. (2022) Diabetes Mellitus as a Risk Factor for Different Types of Cancers: A Systematic Review. Clinical Cancer Investigation Journal 11:4, pages 19-24.
Crossref
Joseph A. M. J. L. Janssen. (2021) Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. International Journal of Molecular Sciences 22:15, pages 7797.
Crossref
Ricardo Imbroisi Filho, Alan C. Ochioni, Amanda M. Esteves, João G. B. Leandro, Thainá M. Demaria, Mauro Sola-Penna & Patricia Zancan. (2021) Western diet leads to aging-related tumorigenesis via activation of the inflammatory, UPR, and EMT pathways. Cell Death & Disease 12:7.
Crossref
Aldona Kasprzak. (2021) Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. International Journal of Molecular Sciences 22:12, pages 6434.
Crossref
Dominika Bhatia, Rinku Sutradhar, Jill Tinmouth, Simron Singh, Cindy Lau & Lorraine L. Lipscombe. (2021) Influence of chronic comorbidities on periodic colorectal cancer screening participation: A population-based cohort study. Preventive Medicine 147, pages 106530.
Crossref
Anni M.Y. Zhang, Elizabeth A. Wellberg, Janel L. Kopp & James D. Johnson. (2021) Hyperinsulinemia in Obesity, Inflammation, and Cancer. Diabetes & Metabolism Journal 45:3, pages 285-311.
Crossref
Santoshi Muppala, Roy Xiao, Jasmine Gajeton, Irene Krukovets, Dmitriy Verbovetskiy & Olga Stenina‐Adognravi. (2020) Thrombospondin‐4 mediates hyperglycemia‐ and TGF ‐beta‐induced inflammation in breast cancer . International Journal of Cancer 148:8, pages 2010-2022.
Crossref
Mariusz Dąbrowski. (2021) Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors. International Journal of Molecular Sciences 22:4, pages 1680.
Crossref
Jingran Cao & Douglas Yee. (2021) Disrupting Insulin and IGF Receptor Function in Cancer. International Journal of Molecular Sciences 22:2, pages 555.
Crossref
Rahul Saxena, Manisha Naithani & Rohit Saluja. (2021) Diabetes and cancer: Treacherous associations. Journal of Cardio-diabetes and metabolic disorders 1:2, pages 31.
Crossref
Sangita Ganguly, Narender Raju Panjagari & Rakesh Kumar Raman. 2021. Oilseeds: Health Attributes and Food Applications. Oilseeds: Health Attributes and Food Applications 253 283 .
Ozkan Alan, Tugba Akin Telli, Bilge Aktas, Sinan Koca, Ilker Nihat Ökten, Rahib Hasanov, Tugba Basoglu, Rukiye Arikan, Nazim Can Demircan, Ozlem Ercelep, Serap Kaya, Mustafa Umit Ugurlu, Handan Kaya, Nalan Akgul Babacan, Faysal Dane & Perran Fulden Yumuk. (2020) Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?. World Journal of Surgical Oncology 18:1.
Crossref
Nam Hee KimYoosoo ChangSung Ryol LeeSeungho RyuHong Joo Kim. (2020) Glycemic Status, Insulin Resistance, and Risk of Pancreatic Cancer Mortality in Individuals With and Without Diabetes. American Journal of Gastroenterology 115:11, pages 1840-1848.
Crossref
Camila Ortiz Gómez, David Romero-Funes, Rene Aleman, Joel S. Frieder, Juliana Henrique, David Gutierrez-Blanco, Kevin P. White, Emanuele Lo Menzo, Samuel Szomstein & Raul J. Rosenthal. (2020) Bariatric surgery decreases the number of first-time hospital admissions for cancer in severely obese patients. A retrospective analysis of the National Inpatient Sample database. Surgery for Obesity and Related Diseases 16:11, pages 1648-1654.
Crossref
Anne Kilvert & Charles Fox. (2020) Hyperinsulinaemia and cancer risk: cause and effect?. Practical Diabetes 37:6, pages 223.
Crossref
Manwen Li, Limin Song, Junhua Yuan, Di Zhang, Caishun Zhang, Yuan Liu, Qian Lin, Haidan Wang, Kaizhen Su, Yanrun Li, Zhengye Ma, Defeng Liu & Jing Dong. (2020) Association Between Serum Insulin and C-Peptide Levels and Breast Cancer: An Updated Systematic Review and Meta-Analysis. Frontiers in Oncology 10.
Crossref
Rachel J. Perry & Gerald I. Shulman. (2020) Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks. Journal of Biological Chemistry 295:42, pages 14379-14390.
Crossref
Y.-N. Lee & T.A. Chowdhury. (2020) Diabetes: an Overview for Clinical Oncologists. Clinical Oncology 32:9, pages 579-590.
Crossref
Emma E. Vincent & Hanieh Yaghootkar. (2020) Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?. Diabetologia 63:9, pages 1706-1717.
Crossref
Iliana C Lega & Lorraine L Lipscombe. (2020) Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications. Endocrine Reviews 41:1, pages 33-52.
Crossref
Dominika Bhatia, Iliana C. Lega, Wei Wu & Lorraine L. Lipscombe. (2019) Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis. Diabetologia 63:1, pages 34-48.
Crossref
Georgia Schilling. 2020. Prävention gastroenterologischer Tumorerkrankungen. Prävention gastroenterologischer Tumorerkrankungen 211 219 .
Joana R. Campos, Patricia Severino, Classius S. Ferreira, Aleksandra Zielinska, Antonello Santini, Selma B. Souto & Eliana B. Souto. (2019) Linseed Essential Oil – Source of Lipids as Active Ingredients for Pharmaceuticals and Nutraceuticals. Current Medicinal Chemistry 26:24, pages 4537-4558.
Crossref
Chang Seok Bang & Jung Hwan Oh. (2019) Diagnosis of Obesity and Related Biomarkers. The Korean Journal of Medicine 94:5, pages 414-424.
Crossref
Olivia Raglan, Ilkka Kalliala, Georgios Markozannes, Sofia Cividini, Marc J. Gunter, Jaya Nautiyal, Hani Gabra, Evangelos Paraskevaidis, Pierre Martin‐Hirsch, Kostas K. Tsilidis & Maria Kyrgiou. (2019) Risk factors for endometrial cancer: An umbrella review of the literature. International Journal of Cancer 145:7, pages 1719-1730.
Crossref
Carmen Jochem, Birgit Wallmann-Sperlich & Michael F. Leitzmann. (2019) The Influence of Sedentary Behavior on Cancer Risk: Epidemiologic Evidence and Potential Molecular Mechanisms. Current Nutrition Reports 8:3, pages 167-174.
Crossref
Geoffrey Livesey, Richard Taylor, Helen F. Livesey, Anette E. Buyken, David J. A. Jenkins, Livia S. A. Augustin, John L. Sievenpiper, Alan W. Barclay, Simin Liu, Thomas M. S. Wolever, Walter C. Willett, Furio Brighenti, Jordi Salas-Salvadó, Inger Björck, Salwa W. Rizkalla, Gabriele Riccardi, Carlo La Vecchia, Antonio Ceriello, Antonia Trichopoulou, Andrea Poli, Arne Astrup, Cyril W. C. Kendall, Marie-Ann Ha, Sara Baer-Sinnott & Jennie C. Brand-Miller. (2019) Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations. Nutrients 11:6, pages 1436.
Crossref
Katharina Nimptsch, Stefan Konigorski & Tobias Pischon. (2019) Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism 92, pages 61-70.
Crossref
Michael T. Marrone, Konstantinos K. Tsilidis, Stephan Ehrhardt, Corinne E. Joshu, Timothy R. Rebbeck, Thomas A. Sellers & Elizabeth A. Platz. (2019) When Is Enough, Enough? When Are More Observational Epidemiologic Studies Needed to Resolve a Research Question: Illustrations Using Biomarker–Cancer Associations. Cancer Epidemiology, Biomarkers & Prevention 28:2, pages 239-247.
Crossref
Xiaoyan Guo, Xinyan Chen, Ce Zhang, Jiahuan Zhang & Chunyu Zhang. (2019) Hyperinsulinemia and thyroid peroxidase antibody in Chinese patients with papillary thyroid cancer. Endocrine Journal 66:8, pages 731-737.
Crossref
Manoj Kumar Gupta, Vemula Sarojamma & Ramakrishna Vadde. 2019. Exploring Pancreatic Metabolism and Malignancy. Exploring Pancreatic Metabolism and Malignancy 35 51 .
Signe Borgquist, Ann H. Rosendahl, Kamila Czene, Nirmala Bhoo-Pathy, Mozhgan Dorkhan, Per Hall & Judith S. Brand. (2018) Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study. Breast Cancer Research 20:1.
Crossref
Helena J. Janse van Rensburg, Dulcie Lai, Taha Azad, Yawei Hao & Xiaolong Yang. (2018) TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1. Cellular Signalling 52, pages 12-22.
Crossref
R. Dankner, L. Keinan Boker, P. Boffetta, R.D. Balicer, H. Murad, A. Berlin, L. Olmer, N. Agai & LS Freedman. (2018) A historical cohort study on glycemic-control and cancer-risk among patients with diabetes. Cancer Epidemiology 57, pages 104-109.
Crossref
Sandeep Nadella, Julian Burks, Abdulhameed Al-Sabban, Gloria Inyang, Juan Wang, Robin D. Tucker, Marie E. Zamanis, William Bukowski, Narayan Shivapurkar & Jill P. Smith. (2018) Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor. American Journal of Physiology-Gastrointestinal and Liver Physiology 315:5, pages G699-G712.
Crossref
Weike Wang, Teresa T Fung, Molin Wang, Stephanie A Smith-Warner, Edward L Giovannucci & Fred K Tabung. (2018) Association of the Insulinemic Potential of Diet and Lifestyle With Risk of Digestive System Cancers in Men and Women. JNCI Cancer Spectrum 2:4.
Crossref
Ritwika Mallik & Tahseen A. Chowdhury. (2018) Metformin in cancer. Diabetes Research and Clinical Practice 143, pages 409-419.
Crossref
Katharina Nimptsch & Kana Wu. (2018) Is Timing Important? The Role of Diet and Lifestyle During Early Life on Colorectal Neoplasia. Current Colorectal Cancer Reports 14:1, pages 1-11.
Crossref
Ankit Goyal, Ami Patel, Manvesh K. Sihag, Nihir Shah & Beenu Tanwar. 2018. Therapeutic, Probiotic, and Unconventional Foods. Therapeutic, Probiotic, and Unconventional Foods 255 274 .
Daniel P. Schauer, Heather Spencer Feigelson, Corinna Koebnick, Bette Caan, Sheila Weinmann, Anthony C. Leonard, J. David Powers, Panduranga R. Yenumula & David E. Arterburn. (2017) Association Between Weight Loss and the Risk of Cancer after Bariatric Surgery. Obesity 25:S2.
Crossref
Antonino Belfiore, Roberta Malaguarnera, Veronica Vella, Michael C Lawrence, Laura Sciacca, Francesco Frasca, Andrea Morrione & Riccardo Vigneri. (2017) Insulin Receptor Isoforms in Physiology and Disease: An Updated View. Endocrine Reviews 38:5, pages 379-431.
Crossref
Heng Sun, Jing Zou, Ling Chen, Xuyu Zu, Gebo Wen & Jing Zhong. (2017) Triple‑negative breast cancer and its?association with obesity (Review). Molecular and Clinical Oncology.
Crossref
Zhihua Du & Vladimir Uversky. (2017) A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes. International Journal of Molecular Sciences 18:10, pages 2010.
Crossref
Alkhansa Salih Mahmoud & Khalid Hussein Bakheit. (2017) Hyperinsulineamia as Risk Factor for Early Breast Cancer Recurrence Linked to Hormone Receptors and Human Epidermal Growth Factor Receptor 2. Journal of Diabetes and Obesity 4:3, pages 1-4.
Crossref
Robert Carreras-Torres, Mattias Johansson, Valerie Gaborieau, Philip C Haycock, Kaitlin H Wade, Caroline L Relton, Richard M Martin, George Davey Smith & Paul Brennan. (2017) The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study. JNCI: Journal of the National Cancer Institute 109:9.
Crossref
Elena ValentinoArianna BellazzoGiulio Di MininDaria SicariMattia ApollonioGiosuè Scognamiglio, Maurizio Di Bonito, Gerardo Botti, Giannino Del SalLicio Collavin. (2017) Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP. Proceedings of the National Academy of Sciences 114:29, pages 7623-7628.
Crossref
Giovanna Muscogiuri, Maria Cristina De Martino, MariaRosaria Negri, Claudia Pivonello, Chiara Simeoli, Francesco Orio, Rosario Pivonello & Annamaria Colao. (2017) Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance. Endocrinology 158:6, pages 1527-1532.
Crossref
Violeta Kallens, Nicolás Tobar, Jessica Molina, Arantzazú Bidegain, Patricio C. Smith, Omar Porras & Jorge Martínez. (2017) Glucose Promotes a Pro-Oxidant and Pro-Inflammatory Stromal Microenvironment Which Favors Motile Properties in Breast Tumor Cells. Journal of Cellular Biochemistry 118:5, pages 994-1002.
Crossref
Jiachen Zheng, Ming Zhao, Jiahui Li, Guoying Lou, Yanyan Yuan, Shizhong Bu & Yang Xi. (2017) Obesity-associated digestive cancers: A review of mechanisms and interventions. Tumor Biology 39:3, pages 101042831769502.
Crossref
Yves Lecarpentier, Victor Claes, Alexandre Vallée & Jean-Louis Hébert. (2017) Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer. PPAR Research 2017, pages 1-9.
Crossref
Ana Elisa LohmannPamela J. GoodwinRowan T. ChlebowskiKathy PanVuk StambolicRyan J.O. Dowling. (2016) Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome. Journal of Clinical Oncology 34:35, pages 4249-4255.
Crossref
Claudio Vernieri, Stefano Casola, Marco Foiani, Filippo Pietrantonio, Filippo de Braud & Valter Longo. (2016) Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions. Cancer Discovery 6:12, pages 1315-1333.
Crossref
Jiayue YangRichard T. Waldron, Hsin-Yuan SuAune MoroHui-Hua ChangGuido EiblKevin Ferreri, Fouad R. Kandeel, Aurelia Lugea, Ling LiStephen J. Pandol. (2016) Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 311:4, pages G675-G687.
Crossref
. 2016. The Glycemic Index. The Glycemic Index 127 155 .
Patrizia Ferroni, Silvia Riondino, Anastasia Laudisi, Ilaria Portarena, Vincenzo Formica, Jhessica Alessandroni, Roberta D’Alessandro, Augusto Orlandi, Leopoldo Costarelli, Francesco Cavaliere, Fiorella Guadagni & Mario Roselli. (2016) Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression. The Oncologist 21:9, pages 1041-1049.
Crossref
Barbara Altieri, Giacomo Tirabassi, Silvia Della Casa, Cristina L. Ronchi, Giancarlo Balercia, Francesco Orio, Alfredo Pontecorvi, Annamaria Colao & Giovanna Muscogiuri. (2016) Adrenocortical tumors and insulin resistance: What is the first step?. International Journal of Cancer 138:12, pages 2785-2794.
Crossref
Elrashdy M. Redwan, Moustafa H. Linjawi & Vladimir N. Uversky. (2016) Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism. Scientific Reports 6:1.
Crossref
Michael H. Schoenberg. (2016) Physical Activity and Nutrition in Primary and Tertiary Prevention of Colorectal Cancer. Visceral Medicine 32:3, pages 199-204.
Crossref
Katharina Nimptsch & Tobias Pischon. 2016. Obesity and Cancer. Obesity and Cancer 199 217 .
Kazuto Harada, Yoshifumi Baba, Takatsugu Ishimoto, Keisuke Kosumi, Ryuma Tokunaga, Daisuke Izumi, Satoshi Ida, Yu Imamura, Shiro Iwagami, Yuji Miyamoto, Yasuo Sakamoto, Naoya Yoshida, Masayuki Watanabe & Hideo Baba. (2015) Low Visceral Fat Content is Associated with Poor Prognosis in a Database of 507 Upper Gastrointestinal Cancers. Annals of Surgical Oncology 22:12, pages 3946-3953.
Crossref
Slavica Tudzarova & Mahasin A. Osman. (2015) The double trouble of metabolic diseases: the diabetes–cancer link. Molecular Biology of the Cell 26:18, pages 3129-3139.
Crossref
Katharina Nimptsch, Krasimira Aleksandrova, Heiner Boeing, Jürgen Janke, Young-Ae Lee, Mazda Jenab, So Yeon Kong, Konstantinos K. Tsilidis, Elisabete Weiderpass, H. Bas Bueno-De-Mesquita, Peter D. Siersema, Eugène H.J.M. Jansen, Antonia Trichopoulou, Anne Tjønneland, Anja Olsen, Chunsen Wu, Kim Overvad, Marie-Christine Boutron-Ruault, Antoine Racine, Heinz Freisling, Verena Katzke, Rudolf Kaaks, Pagona Lagiou, Dimitrios Trichopoulos, Gianluca Severi, Alessio Naccarati, Amalia Mattiello, Domenico Palli, Sara Grioni, Rosario Tumino, Petra H. Peeters, Ingrid Ljuslinder, Hanna Nyström, Jenny Brändstedt, María-José Sánchez, Aurelio Barricarte Gurrea, Catalina Bonet Bonet, María-Dolores Chirlaque, Miren Dorronsoro, José Ramón Quirós, Ruth C. Travis, Kay-Tee Khaw, Nick Wareham, Elio Riboli, Marc J. Gunter & Tobias Pischon. (2015) Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer . International Journal of Cancer 137:4, pages 911-920.
Crossref
Aggela Kallergi, Claire Chambre, Boris Duchemann, Marinos Fysekidis & Hélène Bihan. (2015) Diabetes Mellitus and Colorectal Cancer Risk. Current Colorectal Cancer Reports 11:4, pages 209-216.
Crossref
Helen G. Coleman, Reid M. Ness, Walter E. Smalley, Wei Zheng & Martha J. Shrubsole. (2015) Aspects of dietary carbohydrate intake are not related to risk of colorectal polyps in the Tennessee Colorectal Polyp Study. Cancer Causes & Control 26:8, pages 1197-1202.
Crossref
Laura W. Bowers, Emily L. Rossi, Ciara H. O’Flanagan, Linda A. deGraffenried & Stephen D. Hursting. (2015) The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Frontiers in Endocrinology 6.
Crossref
Katharina Nimptsch & Tobias Pischon. (2015) Body fatness, related biomarkers and cancer risk: an epidemiological perspective. Hormone Molecular Biology and Clinical Investigation 22:2, pages 39-51.
Crossref
Akihisa Hidaka, Shizuka Sasazuki, Atsushi Goto, Norie Sawada, Taichi Shimazu, Taiki Yamaji, Motoki Iwasaki, Manami Inoue, Mitsuhiko Noda, Hisao Tajiri & Shoichiro Tsugane. (2015) Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: The Japan Public Health Center-based prospective study. International Journal of Cancer 136:6, pages 1402-1410.
Crossref
Paola De Marco, Francesca Cirillo, Adele Vivacqua, Roberta Malaguarnera, Antonino Belfiore & Marcello Maggiolini. (2015) Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells. Frontiers in Endocrinology 6.
Crossref
NING ZHU, YUANYUAN ZHANG, YI GONG, JIAN HE & XIAODONG CHEN. (2015) Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis. Biomedical Reports 3:2, pages 235-241.
Crossref
Ross C. McLean & Jennifer Logue. (2014) The Individual and Combined Effects of Obesity and Type 2 Diabetes on Cancer Predisposition and Survival. Current Nutrition Reports 4:1, pages 22-32.
Crossref
P. Maisonneuve & A. B. Lowenfels. (2014) Risk factors for pancreatic cancer: a summary review of meta-analytical studies. International Journal of Epidemiology 44:1, pages 186-198.
Crossref
Victor Sierpina, Lyuba Levine, Juliet McKee, Christina Campbell, Sungmi Lian & Moshe Frenkel. (2015) Nutrition, Metabolism, and Integrative Approaches in Cancer Survivors. Seminars in Oncology Nursing 31:1, pages 42-52.
Crossref
Stefania I. Papatheodorou, Konstantinos K. Tsilidis, Evangelos Evangelou & John P.A. Ioannidis. (2015) Application of credibility ceilings probes the robustness of meta-analyses of biomarkers and cancer risk. Journal of Clinical Epidemiology 68:2, pages 163-174.
Crossref
Pamela J. GoodwinVuk Stambolic. (2015) Impact of the Obesity Epidemic on Cancer. Annual Review of Medicine 66:1, pages 281-296.
Crossref
Ji Min HanTae Yong KimWon Gu KimDong Eun SongSuck Joon HongSung Jin BaeHong-Kyu KimYoung Kee ShongWon Bae Kim. (2015) Association between Serum Gamma-Glutamyl Transferase and Thyroid Cancer in an Ultrasonographically Screened Population. Journal of Korean Thyroid Association 8:1, pages 75.
Crossref
Sarit Ben-Shmuel, Ran Rostoker, Eyal J. Scheinman & Derek LeRoith. 2016. Metabolic Control. Metabolic Control 355 372 .
Michelle T Chan, Gareth E Lim, Søs Skovsø, Yu Hsuan Carol Yang, Tobias Albrecht, Emilyn U Alejandro, Corinne A Hoesli, James M Piret, Garth L Warnock & James D Johnson. (2014) Effects of insulin on human pancreatic cancer progression modeled in vitro. BMC Cancer 14:1.
Crossref
Laura Sciacca, Maria Francesca Cassarino, Marco Genua, Paolo Vigneri, Maria Giovanna Pennisi, Pasqualino Malandrino, Sebastiano Squatrito, Vincenzo Pezzino & Riccardo Vigneri. (2014) Biological Effects of Insulin and Its Analogs on Cancer Cells With Different Insulin Family Receptor Expression. Journal of Cellular Physiology 229:11, pages 1817-1821.
Crossref
B. Vaitheesvaran, K. Hartil, A. Navare, C. Zheng, P. Ó Broin, A. Golden, C. Guha, W. N. Lee, I. J. Kurland & J. E. Bruce. (2014) Role of the tumor suppressor IQGAP2 in metabolic homeostasis: possible link between diabetes and cancer. Metabolomics 10:5, pages 920-937.
Crossref
Leszek Szablewski. (2014) Diabetes mellitus: influences on cancer risk. Diabetes/Metabolism Research and Reviews 30:7, pages 543-553.
Crossref
Ankit Goyal, Vivek Sharma, Neelam Upadhyay, Sandeep Gill & Manvesh Sihag. (2014) Flax and flaxseed oil: an ancient medicine & modern functional food. Journal of Food Science and Technology 51:9, pages 1633-1653.
Crossref
Pikli Batabyal, Stephen Vander Hoorn, Christopher Christophi & Mehrdad Nikfarjam. (2014) Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies. Annals of Surgical Oncology 21:7, pages 2453-2462.
Crossref
Gail L. Matters, Timothy K. Cooper, Christopher O. McGovern, Evan L. Gilius, Jiangang Liao, Brian M. Barth, Mark Kester & Jill P. Smith. (2014) Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat. Digestive Diseases and Sciences 59:6, pages 1180-1191.
Crossref
Alastair M. Thompson. (2014) Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer. Clinical Cancer Research 20:10, pages 2508-2515.
Crossref
Katharina Nimptsch, Vasanti S. Malik, Teresa T. Fung, Tobias Pischon, Frank B. Hu, Walter C. Willett, Charles S. Fuchs, Shuji Ogino, Andrew T. Chan, Edward Giovannucci & Kana Wu. (2014) Dietary patterns during high school and risk of colorectal adenoma in a cohort of middle-aged women. International Journal of Cancer 134:10, pages 2458-2467.
Crossref
Michal KlysikSamita GargSajal PokharelJeffery MeierNayana PatelKavita Garg. (2014) Challenges of Imaging for Cancer in Patients with Diabetes and Obesity. Diabetes Technology & Therapeutics 16:4, pages 266-274.
Crossref
J C de Beer & L Liebenberg. (2014) Does cancer risk increase with HbA1c, independent of diabetes?. British Journal of Cancer 110:9, pages 2361-2368.
Crossref
José O. Alemán, Leonardo H. Eusebi, Luigi Ricciardiello, Kavish Patidar, Arun J. Sanyal & Peter R. Holt. (2014) Mechanisms of Obesity-Induced Gastrointestinal Neoplasia. Gastroenterology 146:2, pages 357-373.
Crossref
Pedro J. Tárraga LópezJuan Solera AlberoJosé Antonio Rodríguez-Montes. (2014) Primary and Secondary Prevention of Colorectal Cancer. Clinical Medicine Insights: Gastroenterology 7, pages CGast.S14039.
Crossref
Pushpendra Singh, Jimi Marin Alex & Felix Bast. (2013) Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer. Medical Oncology 31:1.
Crossref
Concha Cerdá, Carlos Sánchez, Benjamín Climent, Antonio Vázquez, Antonio Iradi, Fátima El Amrani, Ana Bediaga & Guillermo T. Sáez. 2014. Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics. Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics 5 17 .
Carlo La Vecchia & Cristina Bosetti. (2013) Metformin: Are Potential Benefits on Cancer Risk Extended to Cancer Survival?. The Oncologist 18:12, pages 1245-1247.
Crossref
Majed S Alokail, Nasser Al-Daghri, Amal Abdulkareem, Hossam M Draz, Sobhy M Yakout, Abdullah M Alnaami, Shaun Sabico, Amal M Alenad & George P Chrousos. (2013) Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?. BMC Cancer 13:1.
Crossref
Emelie Karnevi, Katarzyna Said, Roland Andersson & Ann H Rosendahl. (2013) Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells. BMC Cancer 13:1.
Crossref
Jeff M. P. Holly, Li Zeng & Claire M. Perks. (2013) Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?. Cancer and Metastasis Reviews 32:3-4, pages 673-705.
Crossref
Myung-Ju Oh, Sun-Ju Yi, Hye Sung Kim, Ji-Hyun Kim, Young-Hwa Jeong, Ton van Agthoven & Byung H. Jhun. (2013) Functional roles of BCAR3 in the signaling pathways of insulin leading to DNA synthesis, membrane ruffling and GLUT4 translocation. Biochemical and Biophysical Research Communications 441:4, pages 911-916.
Crossref
Thomas P. Ahern, Susan E. Hankinson, Walter C. Willett, Michael N. Pollak, A. Heather Eliassen & Rulla M. Tamimi. (2013) Plasma C-Peptide, Mammographic Breast Density, and Risk of Invasive Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention 22:10, pages 1786-1796.
Crossref
Emily J. Gallagher & Derek LeRoith. (2013) Diabetes, antihyperglycemic medications and cancer risk. Current Opinion in Endocrinology, Diabetes & Obesity 20:5, pages 485-494.
Crossref
Ayse Ocak Duran, Cüneyd Anil, Alptekin Gursoy, Aslı Nar, Ozden Altundag & Neslihan Bascil Tutuncu. (2012) The relationship between glucose metabolism disorders and malignant thyroid disease. International Journal of Clinical Oncology 18:4, pages 585-589.
Crossref
Yehuda Handelsman, Derek LeRoith, Zachary T. Bloomgarden, Samuel Dagogo-Jack, Daniel Einhorn, Alan J. Garber, George Grunberger, R. Mack Harrell, Robert F. Gagel, Harold E. Lebovitz, Janet B. McGill & Charles H. Hennekens. (2013) Diabetes and Cancer—An AACE/ACE Consensus Statement. Endocrine Practice 19:4, pages 675-693.
Crossref
Yu-Lung Chen, Kao-Chi Cheng, Shih-Wei Lai, I-Ju Tsai, Che-Chen Lin, Fung-Chang Sung, Cheng-Chieh Lin & Pei-Chun Chen. (2012) Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan. Gastric Cancer 16:3, pages 389-396.
Crossref
Rosalyn D Ferguson, Emily J Gallagher, Dara Cohen, Aviva Tobin-Hess, Nyosha Alikhani, Ruslan Novosyadlyy, Nadine Haddad, Shoshana Yakar & Derek LeRoith. (2013) Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. Endocrine-Related Cancer 20:3, pages 391-401.
Crossref
John C. McAuliffe & John D. Christein. (2013) Type 2 Diabetes Mellitus and Pancreatic Cancer. Surgical Clinics of North America 93:3, pages 619-627.
Crossref
Maria E. Ramos-Nino. (2013) The Role of Chronic Inflammation in Obesity-Associated Cancers. ISRN Oncology 2013, pages 1-25.
Crossref
J. M. Han, T. Y. Kim, M. J. Jeon, J. H. Yim, W. G. Kim, D. E. Song, S. J. Hong, S. J. Bae, H.-K. Kim, M.-H. Shin, Y. K. Shong & W. B. Kim. (2013) Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. European Journal of Endocrinology 168:6, pages 879-886.
Crossref
Christos V. Rizos & Moses S. Elisaf. (2013) Metformin and cancer. European Journal of Pharmacology 705:1-3, pages 96-108.
Crossref
Roslyn Vongsuvanh, Jacob George, Liang Qiao & David van der Poorten. (2013) Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Letters 330:1, pages 1-10.
Crossref
Peter T. Campbell. (2012) The Role of Diabetes and Diabetes Treatments in Colorectal Cancer Mortality, Incidence, and Survival. Current Nutrition Reports 2:1, pages 37-47.
Crossref
Juhua Luo, Rowan Chlebowski, Simin Liu, Katherine A. McGlynn, Niyati Parekh, Donna L. White & Karen L. Margolis. (2012) Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes & Control 24:3, pages 577-585.
Crossref
Samy L. Habib & Maciej Rojna. (2013) Diabetes and Risk of Cancer. ISRN Oncology 2013, pages 1-16.
Crossref
Ana Chocarro-Calvo, Jose Manuel García-Martínez, Soraya Ardila-González, Antonio De la Vieja & Custodia García-Jiménez. (2013) Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer. Molecular Cell 49:3, pages 474-486.
Crossref
Emily J. Gallagher & Derek LeRoith. (2013) Diabetes, Antihyperglycemic Medications and Cancer Risk: Smoke or Fire?. Endocrine Practice 1:-1, pages 1-28.
Crossref
Rosalyne L. Westley & Felicity E. B. May. (2013) A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors. International Journal of Endocrinology 2013, pages 1-37.
Crossref
Giovanni De Pergola & Franco Silvestris. (2013) Obesity as a Major Risk Factor for Cancer. Journal of Obesity 2013, pages 1-11.
Crossref
Meena K. Sakharkar, Babita Shashni, Karun Sharma, Sarinder K. Dhillon, Prabhakar R. Ranjekar & Kishore R. Sakharkar. (2013) Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer. PPAR Research 2013, pages 1-11.
Crossref
J. Hu, C. La Vecchia, L.S. Augustin, E. Negri, M. de Groh, H. Morrison & L. Mery. (2013) Glycemic index, glycemic load and cancer risk. Annals of Oncology 24:1, pages 245-251.
Crossref
Rosalyn D. Ferguson, Emily J. Gallagher, Eyal J. Scheinman, Rawan Damouni & Derek LeRoith. 2013. Hormones and Breast Cancer. Hormones and Breast Cancer 51 98 .
Corinne E. Joshu, Edward Giovannucci & Elizabeth A. Platz. 2013. Women and Health. Women and Health 1209 1219 .
A. Wirth, H. Hauner, M. Roden, K. Parhofer, M. May, St. Engeli, J. Jordan, R. Schulz, K.T.M. Schneider, V.A. Grote, B. Teucher & R. Kaaks. 2013. Adipositas. Adipositas 173 257 .
Gilberto Paz-Filho, Ameet Kumar Mishra & Julio Licinio. 2013. Adipose Tissue and Cancer. Adipose Tissue and Cancer 71 97 .
Bin Bao, Anthony Oraha, Aamir Ahmad, Shadan Ali, Yiwei Li, Asfar S. Azmi, Sanjeev Banerjee & Fazlul H. Sarkar. 2013. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance 117 142 .
Nora L. Nock & Nathan A. Berger. 2013. Exercise, Energy Balance, and Cancer. Exercise, Energy Balance, and Cancer 21 36 .
Konstantinos K. Tsilidis, Stefania I. Papatheodorou, Evangelos Evangelou & John P. A. Ioannidis. (2012) Evaluation of Excess Statistical Significance in Meta-analyses of 98 Biomarker Associations with Cancer Risk. JNCI: Journal of the National Cancer Institute 104:24, pages 1867-1878.
Crossref
Ingrid KohlstadtD Boyd. 2012. Advancing Medicine with Food and Nutrients, Second Edition. Advancing Medicine with Food and Nutrients, Second Edition 699 726 .
V. Formica, M. Tesauro, C. Cardillo & M. Roselli. (2012) Insulinemia and the risk of breast cancer and its relapse. Diabetes, Obesity and Metabolism 14:12, pages 1073-1080.
Crossref
A. Joan Levine, Ugonna Ihenacho, Won Lee, Jane C. Figueiredo, David J. Vandenberg, Christopher K. Edlund, Brian D. Davis, Mariana C. Stern & Robert W. Haile. (2012) Genetic variation in insulin pathway genes and distal colorectal adenoma risk. International Journal of Colorectal Disease 27:12, pages 1587-1595.
Crossref
G-C Chen, Z Pang & Q-F Liu. (2012) Magnesium intake and risk of colorectal cancer: a meta-analysis of prospective studies. European Journal of Clinical Nutrition 66:11, pages 1182-1186.
Crossref
Maria Theresa M. Redaniel, Mona Jeffreys, Margaret T. May, Yoav Ben-Shlomo & Richard M. Martin. (2012) Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women. Cancer Causes & Control 23:11, pages 1785-1795.
Crossref
Jennifer Ligibel. (2012) Lifestyle Factors in Cancer Survivorship. Journal of Clinical Oncology 30:30, pages 3697-3704.
Crossref
D. Aune, D.S.M. Chan, A.R. Vieira, D.A. Navarro Rosenblatt, R. Vieira, D.C. Greenwood, J.E. Cade, V.J. Burley & T. Norat. (2012) Dietary fructose, carbohydrates, glycemic indices and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies. Annals of Oncology 23:10, pages 2536-2546.
Crossref
MICHAEL WEICHHAUS, JOHN BROOM, KLAUS WAHLE & GIOVANNA BERMANO. (2012) A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer. International Journal of Oncology 41:2, pages 745-752.
Crossref
Rachel Dankner, Michael H. Shanik, Lital Keinan-Boker, Cindy Cohen & Angela Chetrit. (2012) Effect of Elevated Basal Insulin on Cancer Incidence and Mortality in Cancer Incident Patients. Diabetes Care 35:7, pages 1538-1543.
Crossref
Carlotta Galeone, Claudio Pelucchi & Carlo La Vecchia. (2012) Added sugar, glycemic index and load in colon cancer risk. Current Opinion in Clinical Nutrition and Metabolic Care 15:4, pages 368-373.
Crossref
M. Barba, F. Sperati, S. Stranges, C. Carlomagno, G. Nasti, V. Iaffaioli, G. Caolo, M. Mottolese, G. Botti, I. Terrenato, P. Vici, D. Serpico, A. Giordano, G. D’Aiuto, A. Crispo, M. Montella, G. Capurso, G. Delle Fave, B. Fuhrman, C. Botti & S. De Placido. (2012) Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort. Annals of Oncology 23:7, pages 1838-1845.
Crossref
Xilin Yang, Wing‐Yee So, Ronald CW Ma, Alice PS Kong, Gang Xu & Juliana CN Chan. (2012) Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry. Diabetes/Metabolism Research and Reviews 28:5, pages 379-387.
Crossref
Davide Soranna, Lorenza Scotti, Antonella Zambon, Cristina BosettiGuido GrassiAlberico Catapano, Carlo La Vecchia, Giuseppe ManciaGiovanni Corrao. (2012) Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta‐Analysis. The Oncologist 17:6, pages 813-822.
Crossref
Katia ScotlandiAntonino Belfiore. (2012) Targeting the Insulin-Like Growth Factor (IGF) System Is Not as Simple as Just Targeting the Type 1 IGF Receptor. American Society of Clinical Oncology Educational Book:32, pages 599-604.
Crossref
J. A. Johnson, B. Carstensen, D. Witte, S. L. Bowker, L. Lipscombe & A. G. Renehan. (2012) Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia 55:6, pages 1607-1618.
Crossref
Verena A. Grote, Sabine Rohrmann, Laure Dossus, Alexandra Nieters, Jytte Halkjær, Anne Tjønneland, Kim Overvad, Jakob Stegger, Nathalie Chabbert‐Buffet, Marie‐Christine Boutron‐Ruault, Françoise Clavel‐Chapelon, Birgit Teucher, Susen Becker, Jukka Montonen, Heiner Boeing, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Domenico Palli, Sabina Sieri, Rosario Tumino, Paolo Vineis, Amalia Mattiello, Marcial Argüelles, Eric J Duell, Esther Molina‐Montes, Nerea Larrañaga, María‐Dolores Chirlaque, Aurelio Barricarte Gurrea, Suzanne M. Jeurnink, Petra HM Peeters, Weimin Ye, Malin Sund, Björn Lindkvist, Dorthe Johansen, Kay‐Tee Khaw, Nick Wareham, Francesca L. Crowe, Isabelle Romieu, Sabina Rinaldi, Mazda Jenab, Dora Romaguera, Dominique S. Michaud, Elio Riboli, H. Bas Bueno‐de‐Mesquita & Rudolf Kaaks. (2011) The association of circulating adiponectin levels with pancreatic cancer risk: A study within the prospective EPIC cohort. International Journal of Cancer 130:10, pages 2428-2437.
Crossref
Roberta Malaguarnera, Antonella Sacco, Concetta Voci, Giuseppe Pandini, Riccardo Vigneri & Antonino Belfiore. (2012) Proinsulin Binds with High Affinity the Insulin Receptor Isoform A and Predominantly Activates the Mitogenic Pathway. Endocrinology 153:5, pages 2152-2163.
Crossref
Nicholas J. Ollberding, Iona Cheng, Lynne R. Wilkens, Brian E. Henderson, Michael N. Pollak, Laurence N. Kolonel & Loïc Le Marchand. (2012) Genetic Variants, Prediagnostic Circulating Levels of Insulin-like Growth Factors, Insulin, and Glucose and the Risk of Colorectal Cancer: The Multiethnic Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 21:5, pages 810-820.
Crossref
D. Aune, D. S. M. Chan, R. Lau, R. Vieira, D. C. Greenwood, E. Kampman & T. Norat. (2012) Carbohydrates, glycemic index, glycemic load, and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Cancer Causes & Control 23:4, pages 521-535.
Crossref
R. J. O. Dowling, S. Niraula, V. Stambolic & P. J. Goodwin. (2012) Metformin in cancer: translational challenges. Journal of Molecular Endocrinology 48:3, pages R31-R43.
Crossref
Ying Bao, Katharina Nimptsch, Andrew T. Chan, Kimmie Ng, Jeffrey A. Meyerhardt, Walter C. Willett, Edward Giovannucci & Charles S. Fuchs. (2011) Reported behavior of eating anything at anytime and risk of colorectal cancer in women. International Journal of Cancer 130:6, pages 1395-1400.
Crossref
T Yamaji, M Iwasaki, S Sasazuki & S Tsugane. (2011) Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia. International Journal of Obesity 36:3, pages 440-447.
Crossref
X Zhang, E L Giovannucci, K Wu, S A Smith-Warner, C S Fuchs, M Pollak, W C Willett & J Ma. (2012) Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study. British Journal of Cancer 106:7, pages 1335-1341.
Crossref
Sabina Sieri, Paola Muti, Agnoli Claudia, Franco Berrino, Valeria Pala, Sara Grioni, Carlo Alberto Abagnato, Giovanni Blandino, Paolo Contiero, Holger J. Schunemann & Vittorio Krogh. (2011) Prospective study on the role of glucose metabolism in breast cancer occurrence. International Journal of Cancer 130:4, pages 921-929.
Crossref
S-Y Park, J-S Kim, Y-R Seo & M-K Sung. (2011) Effects of diet-induced obesity on colitis-associated colon tumor formation in A/J mice. International Journal of Obesity 36:2, pages 273-280.
Crossref
Douglas Edmund FeldmanChialin ChenVasu Punj, Hidekazu Tsukamoto & Keigo Machida. (2011) Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells. Proceedings of the National Academy of Sciences 109:3, pages 829-834.
Crossref
Xi-Lin Yang. (2012) Diabetes, insulin and cancer risk. World Journal of Diabetes 3:4, pages 60.
Crossref
Dong-Jun Kim. (2012) Obesity and Gastrointestinal Cancer-related Factor. The Korean Journal of Gastroenterology 59:1, pages 8.
Crossref
Rikje Ruiter, Loes E. Visser, Myrthe P.P. van Herk-Sukel, Jan-Willem W. Coebergh, Harm R. Haak, Petronella H. Geelhoed-Duijvestijn, Sabine M.J.M. Straus, Ron M.C. Herings & Bruno H.Ch. Stricker. (2012) Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives. Diabetes Care 35:1, pages 119-124.
Crossref
Ian Forrest Robey. (2012) Examining the relationship between diet-induced acidosis and cancer. Nutrition & Metabolism 9:1, pages 72.
Crossref
Roberta Malaguarnera, Alaide Morcavallo & Antonino Belfiore. (2012) The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis. Journal of Oncology 2012, pages 1-19.
Crossref
Christiane D. WrannTobias LaueLena HübnerSusanne KuhlmannRoland Jacobs, Lilia Goudeva & Heike Nave. (2012) Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. American Journal of Physiology-Endocrinology and Metabolism 302:1, pages E108-E116.
Crossref
Freerk T. Baumann, Elke Jäger & Wilhelm BlochKaren Steindorf & Martina Schmidt. 2012. Sport und körperliche Aktivität in der Onkologie. Sport und körperliche Aktivität in der Onkologie 43 54 .
Donghui Li. 2012. Energy Balance and Gastrointestinal Cancer. Energy Balance and Gastrointestinal Cancer 93 109 .
Rosalyn D. Ferguson & Derek LeRoith. 2012. Insulin-like Growth Factors and Cancer. Insulin-like Growth Factors and Cancer 37 72 .
Paige M. Bracci. (2011) Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanisms. Molecular Carcinogenesis 51:1, pages 53-63.
Crossref
Donghui Li. (2011) Diabetes and pancreatic cancer. Molecular Carcinogenesis 51:1, pages 64-74.
Crossref
Kana Wu, Diane Feskanich, Charles S. Fuchs, Andrew T. Chan, Walter C. Willett, Bruce W. Hollis, Michael N. Pollak & Edward Giovannucci. (2011) Interactions between Plasma Levels of 25-Hydroxyvitamin D, Insulin-Like Growth Factor (IGF)-1 and C-Peptide with Risk of Colorectal Cancer. PLoS ONE 6:12, pages e28520.
Crossref
Claire L Donohoe, Suzanne L Doyle & John V Reynolds. (2011) Visceral adiposity, insulin resistance and cancer risk. Diabetology & Metabolic Syndrome 3:1.
Crossref
Xuehong Zhang, Edward L. Giovannucci, Stephanie A. Smith-Warner, Kana Wu, Charles S. Fuchs, Michael Pollak, Walter C. Willett & Jing Ma. (2011) A prospective study of intakes of zinc and heme iron and colorectal cancer risk in men and women. Cancer Causes & Control 22:12, pages 1627-1637.
Crossref
Carlo La Vecchia. (2011) Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk. Metabolism 60:10, pages 1357-1358.
Crossref
Caitlin Mason, Karen E. Foster-Schubert, Ikuyo Imayama, Angela Kong, Liren Xiao, Carolyn Bain, Kristin L. Campbell, Ching-Yun Wang, Catherine R. Duggan, Cornelia M. Ulrich, Catherine M. Alfano, George L. Blackburn & Anne McTiernan. (2011) Dietary Weight Loss and Exercise Effects on Insulin Resistance in Postmenopausal Women. American Journal of Preventive Medicine 41:4, pages 366-375.
Crossref
Antonino Belfiore & Roberta Malaguarnera. (2011) Insulin receptor and cancer. Endocrine-Related Cancer 18:4, pages R125-R147.
Crossref
Zachary T. Bloomgarden. (2011) World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease. Diabetes Care 34:7, pages e115-120.
Crossref
Alison E. Harvey, Laura M. Lashinger & Stephen D. Hursting. (2011) The growing challenge of obesity and cancer: an inflammatory issue. Annals of the New York Academy of Sciences 1229:1, pages 45-52.
Crossref
Evanthia Gouveri, Nikolaos Papanas & Efstratios Maltezos. (2011) The female breast and diabetes. The Breast 20:3, pages 205-211.
Crossref
Brandon L. Pierce, Melissa A. Austin & Habibul Ahsan. (2011) Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes & Control 22:6, pages 877-883.
Crossref
Elizabeth A. Rondini, Alison E. Harvey, Juan P. Steibel, Stephen D. Hursting & Jenifer I. Fenton. (2010) Energy balance modulates colon tumor growth: Interactive roles of insulin and estrogen. Molecular Carcinogenesis 50:5, pages 370-382.
Crossref
Sang Woo Oh, Cheol-Young Park, Eun Sook Lee, Yeong Sook Yoon, Eon Sook Lee, Sang Shin Park, Yuil Kim, Nak Jin Sung, Young Ho Yun, Keun Seok Lee, Han Sung Kang, Youngmee Kwon & Jungsil Ro. (2011) Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Research 13:2.
Crossref
Bin Bao, Zhiwei Wang, Yiwei Li, Dejuan Kong, Shadan Ali, Sanjeev Banerjee, Aamir Ahmad & Fazlul H. Sarkar. (2011) The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1815:2, pages 135-146.
Crossref
Roberta MalaguarneraFrancesco Frasca, Aldo GarozzoFiorenza Gianì, Giuseppe Pandini, Veronica Vella, Riccardo Vigneri & Antonino Belfiore. (2011) Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid. The Journal of Clinical Endocrinology & Metabolism 96:3, pages 766-774.
Crossref
F. Andreelli & C. Amouyal. (2011) Insulinorésistance et cancers. Médecine des Maladies Métaboliques 5:1, pages 23-28.
Crossref
Donghui Li, Hongwei Tang, Manal M. Hassan, Elizabeth A. Holly, Paige M. Bracci & Debra T. Silverman. (2010) Diabetes and risk of pancreatic cancer: a pooled analysis of three large case–control studies. Cancer Causes & Control 22:2, pages 189-197.
Crossref
Peter E. Clayton, Indraneel Banerjee, Philip G. Murray & Andrew G. Renehan. (2010) Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nature Reviews Endocrinology 7:1, pages 11-24.
Crossref

Displaying 200 of 241 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.